MECHANISTIC STUDY OF CLC CHLORIDE-TRANSPORT PROTEINS
CLC 氯离子转运蛋白的机理研究
基本信息
- 批准号:8170014
- 负责人:
- 金额:$ 0.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:BiochemicalBone DiseasesCLC GeneCardiovascular systemCarrier ProteinsChloride IonChloridesComputer Retrieval of Information on Scientific Projects DatabaseDefectDrug Delivery SystemsEpilepsyEpithelialFundingGrantInstitutionKidneyMethodsMuscleNeuronsPhysiologicalPlayProteinsResearchResearch PersonnelResourcesRoleSourceUnited States National Institutes of Healthblood pressure regulationhuman diseaseinhibitor/antagonist
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
CLC chloride-transport proteins are expressed ubiquitously. CLC proteins play central roles in neuronal, muscular, cardiovascular, and epithelial function. Because of these vital physiological roles, many are potential drug targets for treating human disease. Defects in these proteins are responsible for human diseases of kidney and bone, for disorders of blood-pressure regulation, and for epilepsy. Research in the Maduke lab involves a combination of electrophysiological, structural, and biochemical methods. The current study utilizes structural information to understand the mechanism of CLC inhibition. Studies will include inhibitors.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
CLC氯转运蛋白广泛表达。CLC蛋白在神经元、肌肉、心血管和上皮功能中发挥核心作用。 由于这些重要的生理作用,许多是治疗人类疾病的潜在药物靶点。 这些蛋白质的缺陷是人类肾脏和骨骼疾病、血压调节紊乱和癫痫的原因。Maduke实验室的研究涉及电生理学,结构和生物化学方法的组合。 目前的研究利用结构信息来了解CLC抑制的机制。 研究将包括抑制剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRIMPAN I MATHEWS其他文献
IRIMPAN I MATHEWS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRIMPAN I MATHEWS', 18)}}的其他基金
STRUCTURAL STUDY OF HLA-DQ2 AND AN ASSOCIATED COMPLEX
HLA-DQ2 及相关复合物的结构研究
- 批准号:
8362031 - 财政年份:2011
- 资助金额:
$ 0.34万 - 项目类别:
FUNCTIONAL STUDY OF ADP-GLUCOSE PYROPHOSPHORYLASE
ADP-葡萄糖焦磷酸酶的功能研究
- 批准号:
8362108 - 财政年份:2011
- 资助金额:
$ 0.34万 - 项目类别:
相似海外基金
Development of the preventive methods for sports-specific bone diseases in female athletes.
开发女运动员运动特异性骨疾病的预防方法。
- 批准号:
23K10643 - 财政年份:2023
- 资助金额:
$ 0.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Defining the role of aggrecan and type IX collagen in osteoarthritis and osteochondritis dissecans through in vivo studies of genetic bone diseases
通过遗传性骨病的体内研究确定聚集蛋白聚糖和 IX 型胶原蛋白在骨关节炎和剥脱性骨软骨炎中的作用
- 批准号:
MR/X001873/1 - 财政年份:2023
- 资助金额:
$ 0.34万 - 项目类别:
Research Grant
SIK Activators to Treat PTH Pathway Bone Diseases
SIK 激活剂治疗 PTH 通路骨疾病
- 批准号:
10811083 - 财政年份:2023
- 资助金额:
$ 0.34万 - 项目类别:
Functional analysis of a novel membrane transport factor in metabolic bone diseases
一种新型膜转运因子在代谢性骨疾病中的功能分析
- 批准号:
23K09507 - 财政年份:2023
- 资助金额:
$ 0.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
17th Fellows Forum on Osteoporosis and Other Metabolic Bone Diseases
第十七届骨质疏松症和其他代谢性骨疾病研究员论坛
- 批准号:
10753107 - 财政年份:2023
- 资助金额:
$ 0.34万 - 项目类别:
Regenerative therapeutics of bone diseases by means of in situ direct reprogramming
通过原位直接重编程进行骨疾病的再生治疗
- 批准号:
21K19577 - 财政年份:2021
- 资助金额:
$ 0.34万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysis of dysfunction of osteocytes to reveal the targets of treatment in genetical bone diseases
分析骨细胞功能障碍揭示遗传性骨病治疗靶点
- 批准号:
21H02881 - 财政年份:2021
- 资助金额:
$ 0.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
15th Fellows Forum on Osteoporosis and Metabolic Bone Diseases
第十五届骨质疏松症和代谢性骨病研究员论坛
- 批准号:
10318312 - 财政年份:2021
- 资助金额:
$ 0.34万 - 项目类别:
Research for the development of methods to control age-related diseases and bone diseases
研究开发控制与年龄有关的疾病和骨疾病的方法
- 批准号:
20K20496 - 财政年份:2020
- 资助金额:
$ 0.34万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Exploration of druggable targets for metabolic bone diseases using sensitive reporter systems and integrative proteogenomic approaches
使用敏感报告系统和综合蛋白质组学方法探索代谢性骨疾病的药物靶点
- 批准号:
19KK0234 - 财政年份:2019
- 资助金额:
$ 0.34万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))














{{item.name}}会员




